Rare Diseases Clinical Research Network (RDCRN)

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). It supports research and clinical trials for rare diseases, providing a platform for collaboration among patient advocacy groups, clinical investigators, and researchers. The network hosts extensive research publications and resources related to various rare diseases and genetic disorders. The network focuses on advancing knowledge, patient care, and population health for various rare diseases including kidney stones, lung diseases, thrombotic diseases, and Rett syndrome among others. It involves multiple consortia and patient advocacy groups working together to improve understanding, diagnosis, and treatment of rare diseases through research, clinical trials, and patient engagement.